NIP
PRAX icon

Nicholas Investment Partners’s Praxis Precision Medicines PRAX Stock Holding History

Nicholas Investment Partners’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.39M Buy
13,113
+9,165
+232% +$2.9M 0.25% 132
2026
Q1 		$1.27M Buy
+3,948
New +$1.22M 0.09% 170
2025
Q1 		– Sell
-8,481
Closed -$653K – 225
2024
Q4 		$653K Buy
+8,481
New +$614K 0.06% 202

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Nicholas Investment Partners's PRAX Position: Q2 2026 in Review

Nicholas Investment Partners increased its Praxis Precision Medicines (PRAX) stake by 232% in Q2 2026, buying an estimated $2.9M and bringing the position to 13,113 shares worth $4.39M. The position accounts for 0.25% of the portfolio, ranked #132.

Nicholas Investment Partners first reported a position in PRAX in Q4 2024 and has held it in 3 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Nicholas Investment Partners held 13,113 shares of Praxis Precision Medicines worth $4.39M as of Q2 2026.
  • Nicholas Investment Partners bought 9,165 Praxis Precision Medicines shares in Q2 2026, an estimated $2.9M.
  • Praxis Precision Medicines made up 0.25% of Nicholas Investment Partners's portfolio in Q2 2026, its #132 holding.
  • Nicholas Investment Partners first reported a position in Praxis Precision Medicines in Q4 2024 and has held it in 3 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Nicholas Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.